Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00518882

Public ClinicalTrials.gov record NCT00518882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 4:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Liraglutide or Exenatide Added to a Background Treatment of Metformin, Sulphonylurea or a Combination of Both on Glycaemic Control in Subjects With Type 2 Diabetes

Study identification

NCT ID
NCT00518882
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
467 participants

Conditions and interventions

Interventions

  • exenatide Drug
  • liraglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Mar 31, 2008
Completion
Mar 31, 2009
Last update posted
Mar 7, 2017

2007 – 2009

United States locations

U.S. sites
61
U.S. states
24
U.S. cities
57
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35242
Novo Nordisk Investigational Site Goodyear Arizona 85395
Novo Nordisk Investigational Site Artesia California 90701
Novo Nordisk Investigational Site Encino California 91436
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Orange California 92869
Novo Nordisk Investigational Site Sacramento California 95816
Novo Nordisk Investigational Site San Mateo California 94401
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Fort Myers Florida 33907
Novo Nordisk Investigational Site Hollywood Florida 33023
Novo Nordisk Investigational Site Jacksonville Florida 32205
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Jacksonville Florida 32259
Novo Nordisk Investigational Site Longwood Florida 32779
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Pembroke Pines Florida 33029
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Saint Cloud Florida 34769
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Powder Springs Georgia 30127
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Chicago Illinois 60616
Novo Nordisk Investigational Site Peoria Illinois 61615
Novo Nordisk Investigational Site Evansville Indiana 47714
Novo Nordisk Investigational Site Des Moines Iowa 50314-3027
Novo Nordisk Investigational Site New Orleans Louisiana 70121
Novo Nordisk Investigational Site Minneapolis Minnesota 55416
Novo Nordisk Investigational Site Saint Paul Minnesota 55108
Novo Nordisk Investigational Site City of Saint Peters Missouri 63376
Novo Nordisk Investigational Site Flemington New Jersey 08822
Novo Nordisk Investigational Site South Bound Brook New Jersey 08880
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517
Novo Nordisk Investigational Site Canton Ohio 44718
Novo Nordisk Investigational Site Cincinnati Ohio 45206
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19152
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15213
Novo Nordisk Investigational Site Sumter South Carolina 29150
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Corpus Christi Texas 78412
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Houston Texas 77030
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Newport News Virginia 23606
Novo Nordisk Investigational Site Richmond Virginia 23294
Novo Nordisk Investigational Site Olympia Washington 98502
Novo Nordisk Investigational Site Spokane Washington 99218
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00518882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2017 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00518882 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →